chr4-10042008-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000513129.1(SLC2A9):​c.-41+12825G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 151,992 control chromosomes in the GnomAD database, including 1,473 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1473 hom., cov: 33)

Consequence

SLC2A9
ENST00000513129.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.721

Publications

2 publications found
Variant links:
Genes affected
SLC2A9 (HGNC:13446): (solute carrier family 2 member 9) This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
SLC2A9-AS1 (HGNC:40636): (SLC2A9 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.445 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000513129.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC2A9
ENST00000506583.5
TSL:5
c.-175-1744G>A
intron
N/AENSP00000422209.1Q9NRM0-2
SLC2A9
ENST00000513129.1
TSL:3
c.-41+12825G>A
intron
N/AENSP00000426800.1D6REK5
SLC2A9-AS1
ENST00000733256.1
n.319-13851C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
15927
AN:
151874
Hom.:
1464
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.0704
Gnomad EAS
AF:
0.462
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.0736
Gnomad MID
AF:
0.153
Gnomad NFE
AF:
0.0374
Gnomad OTH
AF:
0.0984
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.105
AC:
15964
AN:
151992
Hom.:
1473
Cov.:
33
AF XY:
0.111
AC XY:
8245
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.147
AC:
6109
AN:
41438
American (AMR)
AF:
0.185
AC:
2827
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0704
AC:
244
AN:
3468
East Asian (EAS)
AF:
0.461
AC:
2384
AN:
5174
South Asian (SAS)
AF:
0.162
AC:
778
AN:
4814
European-Finnish (FIN)
AF:
0.0736
AC:
777
AN:
10556
Middle Eastern (MID)
AF:
0.161
AC:
47
AN:
292
European-Non Finnish (NFE)
AF:
0.0374
AC:
2545
AN:
67962
Other (OTH)
AF:
0.103
AC:
216
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
674
1348
2022
2696
3370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0813
Hom.:
180
Bravo
AF:
0.116
Asia WGS
AF:
0.273
AC:
947
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.4
DANN
Benign
0.79
PhyloP100
0.72
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36036984; hg19: chr4-10043632; API